AbbVie Inc. (NYSE: ABBV), a United States-based pharmaceutical company, announced on Friday its quarterly cash dividend.
The company has declared cash dividend of USD1.55 per share.
The cash dividend will be paid to stockholders of record at 15 July 2024 on 15 August 2024.
Eisai forecasts 73% Leqembi revenue growth in FY 2025, boosting BioArctic royalties
ValiRx subsidiary Inaphaea extends drug repurposing deal with Dominion Biotech
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access
Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion
ANI Pharmaceuticals announces buyout of royalty obligation for ILUVIEN and YUTIQ
Sirum collaborates with Governor Wes Moore to expand medication access across Maryland